N: number of studies included; OR: odds ratio; Ph: p value for heterogeneity; BC: breast cancer; LC: liver cancer; SC: squamous cancer; PB: population-based; HB: hospital-based; *OR with statistical s
+ denotes the presence of a disease but the unavailability of recent prevalence estimates; − denotes no known disease prevalence. Sources: [15], [19], [20], [22]–[27].
This profile identifies strengths, challenges and specific areas of action on cancer prevention and care in Bulgaria as part of the European Cancer Inequalities Registry, a flagship initiative of Euro
Organisation for Economic Co-operation and Development70
